GSE115384 CELSR2 knockdown 6 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE115384_CELSR2 knockdown_6_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE115384_CELSR2 knockdown_6_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE115384_CELSR2 knockdown_6_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE115384_CELSR2 knockdown_6_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

H2A clustered histone 19

Gene

non-coding RNA activated by DNA damage

Gene

taxilin gamma Y-linked (pseudogene)

Gene

LHFPL3 antisense RNA 2

Gene

GTPase, very large interferon inducible pseudogene 1

Gene

CDK6 antisense RNA 1

Gene

RGMB antisense RNA 1

Gene

SEPTIN11 divergent transcript

Gene

uncharacterized LOC105375523

Gene

ADAMTS9 antisense RNA 1

  • Gene

    H2A clustered histone 19


  • Gene

    non-coding RNA activated by DNA damage


  • Gene

    taxilin gamma Y-linked (pseudogene)


  • Gene

    LHFPL3 antisense RNA 2


  • Gene

    GTPase, very large interferon inducible pseudogene 1


  • Gene

    CDK6 antisense RNA 1


  • Gene

    RGMB antisense RNA 1


  • Gene

    SEPTIN11 divergent transcript


  • Gene

    uncharacterized LOC105375523


  • Gene

    ADAMTS9 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.